Back to search

Article

Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours:findings from the phase II TALENT trial

2023-03-08

Abstract excerpt

<h4>Background: </h4> More accurate predictive biomarkers in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are needed. This study aims to investigate radiomics-based tumour phenotypes as a surrogate biomarker of the tumour vasculature and response prediction to antiangiogenic targeted agents in patients with GEP-NETs. Methods In this retrospective study, a radiomics signature was developed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
30a6eef2-ce45-5469-8315-a8bd4a654fea
DOI
10.21203/rs.3.rs-2647664/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours:findings from the phase II TALENT trialDOI 10.21203/rs.3.rs-2647664/v1
Select a neighboring publication to make it the new centre.